ClinConnect ClinConnect Logo
Search / Trial NCT06921109

Assessment of the Effectiveness of Virtual Reality as a Learning Tool for Relaxation Techniques in Reducing Pediatric Migraines and Tension Type Headache

Launched by UNIVERSITY OF LIEGE · Apr 7, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Virtual Reality

ClinConnect Summary

This clinical trial is studying how effective virtual reality can be as a learning tool for helping children manage their chronic headaches, including migraines and tension-type headaches. The researchers want to see if using virtual reality can help kids learn relaxation techniques, like deep breathing, and improve their confidence in managing pain. The goal is to reduce the frequency and intensity of headaches right after the program and two months later. They will compare this approach with a similar program that doesn't use virtual reality, as well as a control group that only receives educational information about headaches.

To participate in the trial, children must be between the ages of 2 and 18 and have a history of headaches for at least six months or be diagnosed with migraines or chronic tension-type headaches by a pediatric neurologist. However, children with epilepsy cannot participate. If eligible, participants can expect to engage with virtual reality sessions designed to teach them relaxation skills, and they will have the opportunity to share their experiences and any changes in their headaches during the study. Overall, this trial aims not only to help reduce headaches but also to improve children’s quality of life and their ability to cope with pain.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Having a history of headaches for at least 6 months, or having been diagnosed with migraines and/or chronic tension-type headaches according to the criteria of the International Headache Society (IHS) by a pediatric neurologist.
  • Exclusion Criteria:
  • having an epilepsy disorder

About University Of Liege

The University of Liège, a prestigious research institution in Belgium, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and biomedical engineering, to conduct high-quality research aimed at improving patient outcomes. The institution fosters a rigorous ethical framework and adheres to international standards in clinical research, ensuring the integrity and reliability of its studies. Through its clinical trials, the University of Liège aims to contribute significantly to the development of novel therapeutic approaches and enhance the understanding of complex health issues.

Locations

Sart Tilman, Liege, Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported